Somatostatin analogs for the treatment of cancer
    2.
    发明授权
    Somatostatin analogs for the treatment of cancer 失效
    生长抑素类似物用于治疗癌症

    公开(公告)号:US06316414B1

    公开(公告)日:2001-11-13

    申请号:US09629371

    申请日:2000-07-31

    IPC分类号: A61K3800

    CPC分类号: C07K14/6555 A61K38/00

    摘要: The present invention encompasses novel peptides that are agonists to somatostatin and the use of the agonists for treatment of cancer. The invention particularly relates to the design and synthesis of novel analogs of somatostatin incorporating &agr;, &agr;-dialkylated amino acids in a site specific manner. The invention encompasses methods for the generation of these peptides, compositions containing the peptides and the pharmacological applications of these peptides especially in the treatment and prevention of cancer.

    摘要翻译: 本发明包括作为促生长抑素激动剂的新型肽以及激动剂用于治疗癌症的用途。 本发明特别涉及以特异性位点结合α,α-二烷基化氨基酸的生长抑素的新型类似物的设计和合成。 本发明包括产生这些肽的方法,含有肽的组合物和这些肽的药理学应用,特别是在治疗和预防癌症中。

    Bombesin analogs for treatment of cancer
    4.
    发明授权
    Bombesin analogs for treatment of cancer 失效
    用于治疗癌症的Bombesin类似物

    公开(公告)号:US06989371B1

    公开(公告)日:2006-01-24

    申请号:US09630333

    申请日:2000-07-31

    IPC分类号: A61K38/00 C07K7/00

    CPC分类号: C07K7/086 A61K38/00

    摘要: The present invention encompasses novel peptides that are antagonists to bombesin and bombesin like peptides and are useful in the treatment of cancer. The invention particularly relates to the design and synthesis of the novel peptides incorporating α,α-amino acids in a site specific manner. The invention encompasses methods for the generation of these peptides, compositions containing the peptides and the pharmacological applications of these peptides especially in the treatment and prevention of cancer.

    摘要翻译: 本发明包括作为铃蟾肽和铃蟾肽样肽的拮抗剂的新型肽,并且可用于治疗癌症。 本发明特别涉及以位点特异性方式结合α,α-氨基酸的新型肽的设计和合成。 本发明包括产生这些肽的方法,含有肽的组合物和这些肽的药理学应用,特别是在治疗和预防癌症中。

    Peptides for treatment of cancer
    5.
    发明授权
    Peptides for treatment of cancer 失效
    用于治疗癌症的肽

    公开(公告)号:US06828304B1

    公开(公告)日:2004-12-07

    申请号:US09630345

    申请日:2000-07-31

    IPC分类号: A61K3800

    摘要: This invention relates to novel antiproliferative and anti secrectory peptides that are inhibitory to vasoactive intestinal peptide receptor and are useful in the treatment of cancer. The invention particularly relates to the synthesis of lipid-peptide conjugates containing fatty acids of different sizes, which inhibits the binding of VIP to its receptors. The invention encompasses methods for generation of these peptides, composition containing these peptides and the pharmacological applications of these peptides especially in the treatment and prevention of cancer.

    摘要翻译: 本发明涉及抑制血管活性肠肽受体并可用于治疗癌症的新型抗增殖和抗分解肽。 本发明特别涉及含有不同大小的脂肪酸的脂质 - 肽缀合物的合成,其抑制VIP与其受体的结合。 本发明包括用于产生这些肽的方法,含有这些肽的组合物以及这些肽的药理学应用,特别是在治疗和预防癌症中。

    Substance P analogs for the treatment of cancer
    7.
    发明授权
    Substance P analogs for the treatment of cancer 失效
    物质P类似物治疗癌症

    公开(公告)号:US06596692B1

    公开(公告)日:2003-07-22

    申请号:US09629642

    申请日:2000-07-31

    IPC分类号: A61K3800

    CPC分类号: C07K7/22 A61K38/00

    摘要: The present invention encompasses novel synthetic peptide analogs that are antagonists to Substance P, substance P like peptides and related peptides and are useful for the treatment of cancer. The invention particularly relates to the design and synthesis of the novel substance P antagonist analogs incorporating &agr;,&agr;-dialkylated amino acids in a site specific manner. The invention encompasses methods for the generation of these peptides, compositions containing these peptides and pharmacological applications of these peptides specifically in the treatment and prevention of cancer.

    摘要翻译: 本发明包括对物质P,物质P如肽和相关肽的拮抗剂的新型合成肽类似物,并且可用于治疗癌症。 本发明特别涉及以特定方式结合α,α-二烷基化氨基酸的新物质P拮抗剂类似物的设计和合成。 本发明包括用于产生这些肽的方法,含有这些肽的组合物和这些肽的药理学应用特异性地用于治疗和预防癌症。

    Antiangiogenic drugs
    8.
    发明授权
    Antiangiogenic drugs 失效
    抗血管生成药物

    公开(公告)号:US06492330B1

    公开(公告)日:2002-12-10

    申请号:US09248381

    申请日:1999-02-11

    IPC分类号: A61K3800

    摘要: The invention relates to the use of peptides individually or in combination, for treating and/or preventing angiogenesis. It also relates to the use of peptide analogs or a combination of peptides referred to as MuJ-7 as anticancer drugs in restricting the tumor growth and spread by inhibiting tumor angiogenesis. MuJ-7, in addition inhibits metastasis through its antiangiogenic activity in all cancers. The invention also relates to a pharmaceutical composition containing either individual peptides or in combination, and methods of treatment of human beings and animals for curing and/or preventing angiogenesis.

    摘要翻译: 本发明涉及肽单独或组合用于治疗和/或预防血管生成的用途。 它还涉及肽类似物或被称为MuJ-7的肽的组合作为抗癌药物在限制肿瘤生长和通过抑制肿瘤血管生成而扩散的用途。 MuJ-7还通过其所有癌症中的抗血管生成活性抑制转移。 本发明还涉及含有单个肽或组合的药物组合物,以及用于治疗和/或预防血管生成的人和动物的治疗方法。

    Anticancer activity of imino acid conjugates or methylglyoxal
    10.
    发明授权
    Anticancer activity of imino acid conjugates or methylglyoxal 失效
    甲基乙二醛的亚氨基酸共轭物的抗癌活性

    公开(公告)号:US06613793B2

    公开(公告)日:2003-09-02

    申请号:US10187420

    申请日:2002-07-01

    IPC分类号: A61K3140

    CPC分类号: C07D207/28

    摘要: The invention relates to the use of imino acid conjugates of methylglyoxal for the inhibition and/or treatment of cancer. The invention relates more specifically to the use imino acid conjugates of methylglyoxal for inhibition and/or treatment of cancer of the Colon, Prostate, Larynx, Kidney, Pancreas, Lung, Breast, Intestine, Oral cavity, Ovary, Glioblastoma, and Leukemia. The invention also relates to compositions and methods of inhibiting cancer using imino acid conjugates of methylglyoxal.

    摘要翻译: 本发明涉及甲基乙二醛的亚氨基酸偶联物用于抑制和/或治疗癌症的用途。 本发明更具体地涉及使用甲基乙二醛的亚氨基酸缀合物用于抑制和/或治疗结肠,前列腺,喉,肾,胰腺,肺,乳腺,肠,口腔,卵巢,成胶质细胞瘤和白血病的癌症。 本发明还涉及使用甲基乙二醛的亚氨基酸缀合物抑制癌症的组合物和方法。